Authors:
SE Day, MI Kettunen, MK Cherukuri, JB Mitchell, MJ Lizak, HD Morris, S Matsumoto, AP Koretsky, KM Brindle
Journal name: 
Magn Reson Med
Citation info: 
65(2):557-563
Abstract: 
We show here that hyperpolarized [1-(13) C]pyruvate can be used to detect treatment response in a glioma tumor model; a tumor type where detection of response with (18) fluoro-2-deoxyglucose, using positron emission tomography, is limited by the high background signals from normal brain tissue. (13) C chemical shift images acquired following intravenous injection of hyperpolarized [1-(13) C]pyruvate into rats with implanted C6 gliomas showed significant labeling of lactate within the tumors but comparatively low levels in surrounding brain.Labeled pyruvate was observed at high levels in blood vessels above the brain and from other major vessels elsewhere but was detected at only low levels in tumor and brain.The ratio of hyperpolarized (13) C label in tumor lactate compared to the maximum pyruvate signal in the blood vessels was decreased from 0.38 ± 0.16 to 0.23 ± 0.13, (a reduction of 34%) by 72 h following whole brain irradiation with 15 Gy.
DOI: 
http://doi.org/10.1002/mrm.22698
Research group: 
Brindle Group
E-pub date: 
01 Feb 2011